Towards genetic prediction of radiation responses: ESTRO's GENEPI project

Radiotherapy and Oncology

Volumn 69, Issue 2, 2003, Pages 121-125

  Baumann, Michael ^a   Hölscher, Tobias ^a   Begg, Adrian C ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Clinical outcome data; Genetics; Normal tissue responses; Predictive assays; Radiogenomics; Radiosensitivity; Radiotherapy; Research methodology; Tumour responses

Indexed keywords

ATAXIA; AUTOSOMAL RECESSIVE DISORDER; BREAST CANCER; CANCER CONTROL; COMORBIDITY; DOSE RESPONSE; DOSIMETRY; EDITORIAL; FANCONI ANEMIA; FOLLOW UP; GENE EXPRESSION; GENE MUTATION; GENETIC PREDISPOSITION; HEREDITY; HUMAN; LUNG FIBROSIS; MASTECTOMY; NIJMEGEN BREAKAGE SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RADIATION RESPONSE; RADIOSENSITIVITY; TELANGIECTASIA; TISSUE REACTION; TUMOR VOLUME;

EID: 0344441236     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2003.08.006     Document Type: Editorial

References (72)

1. Alter B.P. Radiosensitivity in Fanconi's anemia patients. Radiother Oncol. 62:2002;345-347.
2. Andreassen C.N., Alsner J., Overgaard J. Does variability in normal tissue reactions after radiotherapy have a genetic basis - where and how to look for it? Radiother Oncol. 64:2002;131-140.
3. Andreassen C.N., Alsner J., Overgaard M., Overgaard J. Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother Oncol. 2003;. this issue.
4. Bakhshi S., Cerosaletti K.M., Concannon P., et al. Medulloblastoma with adverse reaction to radiation therapy in nijmegen breakage syndrome. J Pediatr Hematol Oncol. 25:2003;248-251.
5. Baumann M. Impact of endogeneous and exogeneous factors on radiation sequelae. Dunst J., Sauer R. Late sequelae in oncology. vol. 1.1:1995;3-12 Springer, Berlin.
6. Baumann M., Bentzen S.M. Clinical manifestation of normal-tissue damage. Steel G.G. 3rd ed Basic clinical radiobiology. vol. 11:2002;105-119 Arnold, London.
7. Begg A.C., West C.M.L. Individualization of therapy. Steel G.G. 3rd ed Basic clinical radiobiology. vol. 11:2002;241-252 Arnold, London.
8. Bentzen S.M., Christensen J.J., Overgaard J., Overgaard M. Some methodological problems in estimating radiobiological parameters from clinical data. Alpha/beta ratios and electron RBE for cutaneous reactions in patients treated with postmastectomy radiotherapy. Acta Oncol. 27:1988;105-116.
9. Bentzen S.M., Thames H.D., Travis E.L., et al. Direct estimation of latent time for radiation injury in late-responding normal tissues: gut, lung, and spinal cord. Int J Radiat Biol. 55:1989;27-43.
10. Bentzen S.M., Turesson I., Thames H.D. Fractionation sensitivity and latency of telangiectasia after postmastectomy radiotherapy: a graded-response analysis. Radiother Oncol. 18:1990;95-106.
11. Bentzen S.M., Overgaard M. Relationship between early and late normal-tissue injury after postmastectomy radiotherapy. Radiother Oncol. 20:1991;159-165.
12. Bentzen S.M., Overgaard M., Overgaard J. Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity. Eur J Cancer. 29A:1993;1373-1376.
13. Bentzen S.M. Radiobiological considerations in the design of clinical trials. Radiother Oncol. 32:1994;1-11.
14. Bentzen S.M., Overgaard J. Patient-to-patient variability in the expression of radiation-induced normal tissue injury. Semin Radiat Oncol. 4:1994;68-80.
15. Bentzen S.M., Vaeth M., Pedersen D.E., Overgaard J. Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment... now! Int J Radiat Oncol Biol Phys. 32:1995;1531-1534.
16. Bentzen S.M., Thames H.D. Dose-response relationships for late radiation effects in the head and neck: regarding the analysis of the RTOG 8313 trial, Fu et al. IJROBP 32:577-588; 1995. Int J Radiat Oncol Biol Phys. 34:1996;523-525.
17. Bentzen S.M., Tucker S.L. Quantifying the position and steepness of radiation dose-response curves. Int J Radiat Biol. 71:1997;531-542.
18. Bentzen S.M., Bernier J., Davis J.B., et al. Clinical impact of dosimetry quality assurance programmes assessed by radiobiological modelling of data from the thermoluminescent dosimetry study of the European Organization for Research and Treatment of Cancer. Eur J Cancer. 36:2000;615-620.
19. Bentzen S.M., Saunders M.I., Dische S., Bond S.J. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Radiother Oncol. 60:2001;123-135.
20. Bentzen S.M. Dose-response relationships in radiotherapy. Steel G.G. Basic clinical radiobiology. 3rd ed :2002;94-104 Arnold, London.
21. Borgmann K., Roper B., El-Awady R., et al. Indicators of late normal tissue response after radiotherapy for head and neck cancer: fibroblasts, lymphocytes, genetics, DNA repair, and chromosome aberrations. Radiother Oncol. 64:2002;141-152.
22. Brahme A. Dosimetric precision requirements in radiation therapy. Acta Radiol Oncol. 23:1984;379-391.
23. (in press) Bremer M., Klöppler K., Yamini P., Bendix-Waltes R., Dörk T., Karstens J.H. Clinical radiosensitivity in breast cancer patients carrying pathogenic ATM gene mutations: no observation of increased radiation-induced acute or late effects. Radiother Oncol. 2003.
24. Budach W., Classen J., Belka C., Bamberg M. Clinical impact of predictive assays for acute and late radiation morbidity. Strahlenther Onkol. 174:(Suppl 3):1998;20-24.
25. Burnet N.G., Nyman J., Turesson I., Wurm R., Yarnold J.R., Peacock J.H. Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity. Lancet. 339:1992;1570-1571.
26. Burnet N.G., Peacock J.H. Normal cellular radiosensitivity in an adult Fanconi anaemia patient with marked clinical radiosensitivity. Radiother Oncol. 62:2002;350-351. author reply 350-1.
27. Deschavanne P.J., Debieu D., Fertil B., Malaise E.P. Re-evaluation of in vitro radiosensitivity of human fibroblasts of different genetic origins. Int J Radiat Biol Relat Stud Phys Chem Med. 50:1986;279-293.
28. Dickson J., Magee B., Stewart A., West C.M. Relationship between residual radiation-induced DNA double-strand breaks in cultured fibroblasts and late radiation reactions: a comparison of training and validation cohorts of breast cancer patients. Radiother Oncol. 62:2002;321-326.
29. Dikomey E., Borgmann K., Peacock J., Jung H. Why recent studies relating normal tissue response to individual radiosensitivity might have failed and how new studies should be performed. Int J Radiat Oncol Biol Phys. 56:2003;1194-1200.
30. Dische S., Saunders M.I. Complexity and simplicity in the measurement and recording of the adverse effects of cancer treatment. Radiother Oncol. 66:2003;249-251.
31. Distel L., Neubauer S., Varon R., Holter W., Grabenbauer G. Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome. Med Pediatr Oncol. 41:2003;44-48.
32. Djuzenova C.S., Rothfuss A., Oppitz U., et al. Response to X-irradiation of Fanconi anemia homozygous and heterozygous cells assessed by the single-cell gel electrophoresis (comet) assay. Lab Invest. 81:2001;185-192.
33. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 21:1991;109-122.
34. Esparza A., Thompson W.R. Familial hypoplastic anemia with multiple congenital anomalies (Fanconi's syndrome) - report of three cases. Cases presented are of two sisters and a female cousin with complete clinical and post mortem findings. R I Med J. 49:1966;103-110.
35. Fiorino C., Cozzarini C., Vavassori M., et al. Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions. Radiother Oncol. 64:2002;1-12.
36. Gatti R.A. The inherited basis of human radiosensitivity. Acta Oncol. 40:2001;702-711.
37. Geara F.B., Peters L.J., Ang K.K., Wike J.L., Brock W.A. Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys. 27:1993;1173-1179.
38. Gotoff S.P., Amirmokri E., Liebner E.J. Ataxia telangiectasia. Neoplasia, untoward response to X-irradiation, and tuberous sclerosis. Am J Dis Child. 114:1967;617-625.
39. Haston C.K., Travis E.L. Murine susceptibility to radiation-induced pulmonary fibrosis is influenced by a genetic factor implicated in susceptibility to bleomycin-induced pulmonary fibrosis. Cancer Res. 57:1997;5286-5291.
40. Hendry J.H. Genomic instability: potential contributions to tumour and normal tissue response, and second tumours, after radiotherapy. Radiother Oncol. 59:2001;117-126.
41. Holthusen H. Erfahrungen über die Verträglichkeitsgrenze für Röntgenstrahlen und deren Nutzanwendung zur Verhütung von Schäden. Strahlenther. 57:1936;254-269.
42. Jereczek-Fossa B.A., Garibaldi C., Catalano G., et al. Analysis of mandibular dose distribution in radiotherapy for oropharyngeal cancer: dosimetric and clinical results in 18 patients. Radiother Oncol. 66:2003;49-56.
43. Johansen J., Bentzen S.M., Overgaard J., Overgaard M. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiother Oncol. 40:1996;101-109.
44. Johnston C.J., Williams J.P., Okunieff P., Finkelstein J.N. Radiation-induced pulmonary fibrosis: examination of chemokine and chemokine receptor families. Radiat Res. 157:2002;256-265.
45. Jung H., Beck-Bornholdt H.P., Svoboda V., Alberti W., Herrmann T. Quantification of late complications after radiation therapy. Radiother Oncol. 61:2001;233-246.
46. Koc M., Polat P., Suma S. Effects of tamoxifen on pulmonary fibrosis after cobalt-60 radiotherapy in breast cancer patients. Radiother Oncol. 64:2002;171-175.
47. Kuechler A., Neubauer S., Grabenbauer G.G., et al. Is 24-color FISH detection of in-vitro radiation-induced chromosomal aberrations suited to determine individual intrinsic radiosensitivity? Strahlenther Onkol. 178:2002;209-215.
48. Marcou Y., D'Andrea A., Jeggo P.A., Plowman P.N. Normal cellular radiosensitivity in an adult Fanconi anaemia patient with marked clinical radiosensitivity. Radiother Oncol. 60:2001;75-79.
49. Mariano Ruiz de Almodovar J., Guirado D., Isabel Nunez M., et al. Individualization of radiotherapy in breast cancer patients: possible usefulness of a DNA damage assay to measure normal cell radiosensitivity. Radiother Oncol. 62:2002;327-333.
50. Muren L.P., Maurstad G., Hafslund R., Anker G., Dahl O. Cardiac and pulmonary doses and complication probabilities in standard and conformal tangential irradiation in conservative management of breast cancer. Radiother Oncol. 62:2002;173-183.
51. Okunieff P., Morgan D., Niemierko A., Suit H.D. Radiation dose-response of human tumors. Int J Radiat Oncol Biol Phys. 32:1995;1227-1237.
52. Oppitz U., Schulte S., Stopper H., et al. In vitro radiosensitivity measured in lymphocytes and fibroblasts by colony formation and comet assay: comparison with clinical acute reactions to radiotherapy in breast cancer patients. Int J Radiat Biol. 78:2002;611-616.
53. Overgaard J., Bartelink H. About tolerance and quality. An important notice to all radiation oncologists. Radiother Oncol. 35:1995;1-3.
54. Pavy J.-J., Denekamp J., Letschert J., et al. Late effects toxicity scoring: the SOMA scale. Radiother Oncol. 35:1995;11-15.
55. Plowman P.N., Tsang D. Normal cellular radiosensitivity in an adult Fanconi anaemia patient with marked clinical radiosensitivity (2). Radiother Oncol. 62:2002;351-352.
56. Quarmby S., West C., Magee B., Stewart A., Hunter R., Kumar S. Differential expression of cytokine genes in fibroblasts derived from skin biopsies of patients who developed minimal or severe normal tissue damage after radiotherapy. Radiat Res. 157:2002;243-248.
57. Raaphorst G.P., Malone S., Alsbeih G., Souhani L., Szumacher E., Girard A. Skin fibroblasts in vitro radiosensitivity can predict for late complications following AVM radiosurgery. Radiother Oncol. 64:2002;153-156.
58. Rancati T., Ceresoli G.L., Gagliardi G., Schipani S., Cattaneo G.M. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study. Radiother Oncol. 67:2003;275-283.
59. Rubin P., Casarett G.W. Clinical radiation pathology as applied to curative radiotherapy. Cancer. 22:1968;767-778.
60. Rudat V., Dietz A., Conradt C., Weber K.J., Flentje M. In vitro radiosensitivity of primary human fibroblasts. Lack of correlation with acute radiation toxicity in patients with head and neck cancer. Radiother Oncol. 43:1997;181-188.
61. Russell N.S., Begg A.C. Editorial radiotherapy and oncology 2002: predictive assays for normal tissue damage. Radiother Oncol. 64:2002;125-129.
62. Safwat A., Bentzen S.M., Turesson I., Hendry J.H. Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy. Int J Radiat Oncol Biol Phys. 52:2002;198-204.
63. Skwarchuk M.W., Travis E.L. Murine strain differences in the volume effect and incidence of radiation-induced colorectal obstruction. Int J Radiat Oncol Biol Phys. 41:1998;889-895.
64. Taylor A.M., Metcalfe J.A., Oxford J.M., Harnden D.G. Proceedings: the radiosensitivity at the chromosomal level of lymphocytes from patients with ataxia telangiectasia. Br J Radiol. 49:1976;561.
65. Trotti A., Byhardt R., Stetz J., et al. Common toxicity criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys. 47:2000;13-47.
66. Turesson I. Individual variation and dose dependency in the progression rate of skin telangiectasia. Int J Radiat Oncol Biol Phys. 19:1990;1569-1574.
67. Twardella D., Chang-Claude J. Studies on radiosensitivity from an epidemiological point of view - overview of methods and results. Radiother Oncol. 62:2002;249-260.
68. van de Vijver M.J., He Y.D., van't Veer L.J., et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 347:2002;1999-2009.
69. van Eerde M.R., Kampinga H.H., Szabo B.G., Vujaskovic Z. Comparison of three rat strains for development of radiation-induced lung injury after hemithoracic irradiation. Radiother Oncol. 58:2001;313-316.
70. van't Veer L.J., Dai H., van de Vijver M.J., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 415:2002;530-536.
71. West C.M., Davidson S.E., Elyan S.A., et al. Lymphocyte radiosensitivity is a significant prognostic factor for morbidity in carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 51:2001;10-15.
72. Widel M., Jedrus S., Lukaszczyk B., Raczek-Zwierzycka K., Swierniak A. Radiation-induced micronucleus frequency in peripheral blood lymphocytes is correlated with normal tissue damage in patients with cervical carcinoma undergoing radiotherapy. Radiat Res. 159:2003;713-721.